Back to Results
First PageMeta Content
Omalizumab / Asthma / Urticaria / Allergy / Methadone / Peak expiratory flow / Spirometry / Leukotriene antagonist / Pulmonology / Medicine / Respiratory therapy


Omalizumab (Xolair®) Injectable Medication Precertification Request Aetna Precertification Notification 503 Sunport Lane, Orlando, FL[removed]Phone: [removed]
Add to Reading List

Document Date: 2014-01-21 04:18:02

Open Document

File Size: 669,50 KB

Share Result on Facebook

City

Orlando / /

Company

M.D. D. / /

/

IndustryTerm

fraudulent insurance act / insurance / /

MedicalCondition

acute asthma / syncope / bronchospasm / urticaria / angioedema / severe chronic idiopathic urticaria / chest tightness / dyspnea / shortness of breath / severe persistent allergic asthma / tiredness / e.g. coughing / anaphylaxis / coughing / wheezing / ASTHMA / hypotension / /

Organization

Medicare / /

/

Position

Physician / Pediatrician / controller / /

Product

Injectable Medication / Xolair / /

ProvinceOrState

Florida / /

Technology

cellular telephone / /

SocialTag